Alaunos Therapeutics Inc (TCRT) — Cash Flow-to-Debt Ratio
Alaunos Therapeutics Inc (TCRT) has a Cash Flow-to-Debt Ratio of -0.68x as of December 2025, meaning its operating cash flow of $-552.00K could theoretically repay -1% of its total liabilities ($813.00K) in one year. See TCRT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alaunos Therapeutics Inc Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Alaunos Therapeutics Inc across 25 annual periods. Also explore Alaunos Therapeutics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Alaunos Therapeutics Inc (2001–2025)
Year-by-year debt coverage analysis for Alaunos Therapeutics Inc. For market capitalisation and broader financial context, see how much is Alaunos Therapeutics Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.53x | $-2.87 Million | $813.00K | ▲ +50.9% |
| 2024 | -7.18x | $-4.97 Million | $692.00K | ▲ +53.4% |
| 2023 | -15.41x | $-30.14 Million | $1.96 Million | ▼ -1290.8% |
| 2022 | -1.11x | $-29.23 Million | $26.38 Million | ▲ +33.6% |
| 2021 | -1.67x | $-61.47 Million | $36.81 Million | ▲ +34.5% |
| 2020 | -2.55x | $-57.01 Million | $22.36 Million | ▲ +12.0% |
| 2019 | -2.90x | $-40.85 Million | $14.10 Million | ▲ +44.4% |
| 2018 | -5.21x | $-49.46 Million | $9.49 Million | ▼ -1830.2% |
| 2017 | -0.27x | $-54.67 Million | $202.41 Million | ▲ +15.0% |
| 2016 | -0.32x | $-58.33 Million | $183.65 Million | ▼ -210633.6% |
| 2015 | 0.00x | $-10.00K | $66.35 Million | ▲ +100.0% |
| 2014 | -3.22x | $-36.65 Million | $11.40 Million | ▼ -20.9% |
| 2013 | -2.66x | $-59.51 Million | $22.37 Million | ▼ -18.0% |
| 2012 | -2.25x | $-78.83 Million | $34.96 Million | ▼ -111.9% |
| 2011 | -1.06x | $-38.84 Million | $36.50 Million | ▼ -67.3% |
| 2010 | -0.64x | $-19.69 Million | $30.97 Million | ▼ -11.9% |
| 2009 | -0.57x | $-12.29 Million | $21.63 Million | ▲ +85.9% |
| 2008 | -4.03x | $-23.52 Million | $5.83 Million | ▼ -18.4% |
| 2007 | -3.41x | $-21.65 Million | $6.36 Million | ▲ +29.6% |
| 2006 | -4.84x | $-14.42 Million | $2.98 Million | ▼ -26.3% |
| 2005 | -3.83x | $-8.78 Million | $2.29 Million | ▼ -1003.4% |
| 2004 | -0.35x | $-7.31K | $21.05K | ▲ +4.2% |
| 2003 | -0.36x | $-9.33K | $25.72K | ▲ +45.0% |
| 2002 | -0.66x | $-11.77K | $17.84K | ▲ +88.0% |
| 2001 | -5.50x | $-30.26K | $5.50K | — |